OVID logo

Ovid Therapeutics (OVID) Working Capital

Annual Working Capital

$98.12 M
-$26.27 M-21.12%

December 31, 2023


Summary


Performance

OVID Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOVIDbalance sheetmetrics:

Quarterly Working Capital

$54.20 M
-$12.57 M-18.83%

September 30, 2024


Summary


Performance

OVID Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherOVIDbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

OVID Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-21.1%0.0%
3 y3 years+85.9%0.0%
5 y5 years+177.0%0.0%

OVID Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-44.1%at low-69.2%at low
5 y5-year-44.1%+85.9%-75.4%+83.6%
alltimeall time-44.1%+177.0%-75.4%+88.3%

Ovid Therapeutics Working Capital History

DateAnnualQuarterly
Sep 2024
-
$54.20 M(-18.8%)
Jun 2024
-
$66.77 M(-20.8%)
Mar 2024
-
$84.27 M(-14.1%)
Dec 2023
$98.12 M(-21.1%)
$98.12 M(+18.1%)
Sep 2023
-
$83.05 M(-9.8%)
Jun 2023
-
$92.03 M(-18.4%)
Mar 2023
-
$112.80 M(-9.3%)
Dec 2022
$124.39 M(-29.2%)
$124.39 M(-7.0%)
Sep 2022
-
$133.77 M(-8.9%)
Jun 2022
-
$146.87 M(-8.1%)
Mar 2022
-
$159.86 M(-9.0%)
Dec 2021
$175.68 M(+232.9%)
$175.68 M(-9.9%)
Sep 2021
-
$194.99 M(-4.7%)
Jun 2021
-
$204.58 M(-7.1%)
Mar 2021
-
$220.32 M(+317.4%)
Dec 2020
$52.78 M
$52.78 M(-27.1%)
DateAnnualQuarterly
Sep 2020
-
$72.39 M(+145.2%)
Jun 2020
-
$29.52 M(-41.8%)
Mar 2020
-
$50.75 M(-26.8%)
Dec 2019
$69.28 M(+95.6%)
$69.28 M(+140.6%)
Sep 2019
-
$28.79 M(-35.2%)
Jun 2019
-
$44.42 M(-18.9%)
Mar 2019
-
$54.75 M(+54.6%)
Dec 2018
$35.42 M(-57.1%)
$35.42 M(-21.0%)
Sep 2018
-
$44.83 M(-22.3%)
Jun 2018
-
$57.69 M(-16.5%)
Mar 2018
-
$69.11 M(-16.3%)
Dec 2017
$82.57 M(+69.6%)
$82.57 M(-10.5%)
Sep 2017
-
$92.26 M(-8.0%)
Jun 2017
-
$100.25 M(+140.6%)
Mar 2017
-
$41.67 M(-14.4%)
Dec 2016
$48.68 M(-28.4%)
$48.68 M
Dec 2015
$67.97 M
-

FAQ

  • What is Ovid Therapeutics annual working capital?
  • What is the all time high annual working capital for Ovid Therapeutics?
  • What is Ovid Therapeutics annual working capital year-on-year change?
  • What is Ovid Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Ovid Therapeutics?
  • What is Ovid Therapeutics quarterly working capital year-on-year change?

What is Ovid Therapeutics annual working capital?

The current annual working capital of OVID is $98.12 M

What is the all time high annual working capital for Ovid Therapeutics?

Ovid Therapeutics all-time high annual working capital is $175.68 M

What is Ovid Therapeutics annual working capital year-on-year change?

Over the past year, OVID annual working capital has changed by -$26.27 M (-21.12%)

What is Ovid Therapeutics quarterly working capital?

The current quarterly working capital of OVID is $54.20 M

What is the all time high quarterly working capital for Ovid Therapeutics?

Ovid Therapeutics all-time high quarterly working capital is $220.32 M

What is Ovid Therapeutics quarterly working capital year-on-year change?

Over the past year, OVID quarterly working capital has changed by $0.00 (0.00%)